14 of the tested peptides showed biological activity, with 3 exhibiting single-digit nanomolar potency – performance typically achieved only after multiple design iterations.
Rapid Peptide Discovery for GLP-1R by using Generative Biologics engine
Designed 5,000+ novel candidates in 72 hours — enabling rapid screening without iterative cycles.
Based on predicted affinity scores and binding energy calculations, 20 top candidates were synthesized and evaluated, revealing 14 biologically active peptides—including 3 with exceptional single-digit nanomolar potency— typically requiring multiple design cycles to achieve.
At GenScript, our AI-guided library design platform leverages this approach to help you design and deploy custom peptide libraries from scratch, rapidly and with high precision. Whether you’re targeting receptor families (e.g., GLP-1R), immuno-targets or proteomics, we stand ready to turn advanced algorithms into tangible screening assets.
*Collaborating with Insilico Medicine — a global leader in AI for biotechnology.